W. Brooks Gentry

Fundador en InterveXion Therapeutics LLC .

Health Technology

Consumer Services

Perfil

W.
Brooks Gentry is the founder and Chief Medical Officer of InterveXion Therapeutics LLC, which is founded in 2004.
He is currently a Professor at The University of Arkansas, a position he has held since 2000.

Cargos activos de W. Brooks Gentry

Empresas	Cargo	Inicio
InterveXion Therapeutics LLC InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR.	Fundador	17/09/2009
The University of Arkansas	Corporate Officer/Principal	17/09/2009

Todos los cargos activos de W. Brooks Gentry

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de W. Brooks Gentry.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
InterveXion Therapeutics LLC InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR.	Health Technology